Meningococcal Polysaccharide Diphtheria Toxoid Vaccine About
MENACTRA offers an affordable yet supreme value in immunization, blending venerable medical expertise with uncommon safety standards. This Meningococcal Polysaccharide Diphtheria Toxoid Vaccine, with a strength of 16mcg/48mcg, is engineered for the prevention of meningococcal infections in adults and children above 9 months. Utilise this offer to secure single-dose protection via intramuscular injection. Each box includes a clear liquid solution in a 0.5 ml vial and informative leaflet. MENACTRA is the trusted choice for traders, exporters, and suppliers seeking reliable immunization solutions in India.
Application Media and Versatile Uses
The Meningococcal Polysaccharide Diphtheria Toxoid Vaccine is ideal for clinical settings, public health programs, and immunization drives. It is highly suitable for use in hospitals, vaccination centers, and travel clinics targeting the prevention of meningococcal disease. This vaccine safeguards individuals aged above 9 months, encompassing both children and adults, as directed by a physician. Its liquid form allows hassle-free intramuscular administration and delivers efficient coverage against four meningococcal groups.
Export, Domestic Reach, and Seamless Payment
With steady arrival schedules, MENACTRA is widely available for export, reaching international and regional markets. In India, suppliers and traders provide goods transport at the lowest price, ensuring cost-effective distribution. Main export markets include Asia, Africa, and the Middle East, while domestic markets span across urban and rural healthcare providers. Flexible payment terms support reliable order fulfillment, allowing timely access to the vaccine for preventive healthcare initiatives.
FAQ's of Meningococcal Polysaccharide Diphtheria Toxoid Vaccine:
Q: How is the Meningococcal Polysaccharide Diphtheria Toxoid Vaccine administered?
A: This vaccine is administered as a single 0.5 ml intramuscular injection, typically in the upper arm or thigh, under the supervision of a healthcare professional.
Q: What is the main benefit of using MENACTRA for immunization?
A: MENACTRA provides effective, broad-spectrum protection against meningococcal infection caused by Groups A, C, Y, and W-135, helping reduce the risk of life-threatening disease for both children and adults.
Q: When should this vaccine be given?
A: The vaccine is suitable for individuals aged above 9 months and should be administered according to a healthcare provider's recommendation, especially before entering high-risk environments or regions where meningococcal disease is more prevalent.
Q: Where should MENACTRA be stored before use?
A: MENACTRA should be stored in a refrigerator at a temperature between 2C and 8C to maintain efficacy until the expiry date indicated on the vial.
Q: What usage guidelines should be followed for this vaccine?
A: Always follow the dosage and administration instructions provided by a physician. Use only the full contents of the single-dose vial and dispose of it properly after use.